Notably, the expression of YAP/TAZ has recently been reported to be elevated in high-grade and triple-negative breast cancers by comparison with other subtypes, and is associated with their poor prognosis, tumor growth and metastatic ability [8–11]. The gene discussed is YAP1; the disease is triple-negative breast carcinoma.